Retinoblastoma cells activate the AKT pathway and are vulnerable to the PI3K/mTOR inhibitor NVP-BEZ235

Chencheng Xie, Matthew J. Freeman, Huarui Lu, Xiaohong Wang, Colleen L. Forster, Aaron L. Sarver, Timothy C. Hallstrom

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Retinoblastoma cells activate the AKT pathway and are vulnerable to the PI3K/mTOR inhibitor NVP-BEZ235'. Together they form a unique fingerprint.

Medicine & Life Sciences